Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
RXO Stock Forecast 2026-2027
$19.58
Current Price
$3.23B
Market Cap
Buy 5
Hold 14
Sell 2
Wall St Analyst Ratings
Distance to RXO Price Targets
+2.1%
To High Target of $20.00
-23.4%
To Median Target of $15.00
-38.7%
To Low Target of $12.00
RXO Price Momentum
+18.9%
1 Week Change
+48.0%
1 Month Change
+53.2%
1 Year Change
+54.9%
Year-to-Date Change
-3.0%
From 52W High of $20.19
+87.8%
From 52W Low of $10.43
📊 TOP ANALYST CALLS
Did RXO Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if RXO is one of their latest high-conviction picks.
Latest RXO Stock Price Targets & Analyst Predictions
Based on our analysis of 24 Wall Street analysts, RXO has a neutral consensus with a median price target of $15.00 (ranging from $12.00 to $20.00). The overall analyst rating is Buy (6.5/10). Currently trading at $19.58, the median forecast implies a -23.4% downside. This outlook is supported by 5 Buy, 14 Hold, and 2 Sell ratings.
The most optimistic forecast comes from Lucas Servera at Truist Securities, projecting a 2.1% upside. Conversely, the most conservative target is provided by Bascome Majors at Susquehanna, suggesting a 38.7% downside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
RXO Analyst Ratings
5
Buy
14
Hold
2
Sell
RXO Price Target Range
Low
$12.00
Average
$15.00
High
$20.00
Current: $19.58
Latest RXO Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for RXO.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Mar 25, 2026 | B of A Securities | Ken Hoexter | Neutral | Maintains | $15.00 |
| Mar 4, 2026 | Barclays | Brandon Oglenski | Overweight | Maintains | $17.00 |
| Feb 9, 2026 | Truist Securities | Lucas Servera | Buy | Maintains | $20.00 |
| Feb 9, 2026 | Citigroup | Ariel Rosa | Neutral | Maintains | $18.00 |
| Feb 8, 2026 | UBS | Neutral | Maintains | $N/A | |
| Jan 15, 2026 | Truist Securities | Lucas Servera | Buy | Maintains | $18.00 |
| Jan 9, 2026 | TD Cowen | Jason Seidl | Hold | Maintains | $14.00 |
| Jan 8, 2026 | Citigroup | Ariel Rosa | Neutral | Maintains | $15.00 |
| Jan 8, 2026 | Susquehanna | Bascome Majors | Negative | Maintains | $11.00 |
| Dec 16, 2025 | Stifel | J. Bruce Chan | Hold | Maintains | $16.00 |
| Nov 14, 2025 | Wolfe Research | Jacob Lacks | Peer Perform | Upgrade | $N/A |
| Nov 11, 2025 | Morgan Stanley | Ravi Shanker | Overweight | Upgrade | $19.00 |
| Nov 7, 2025 | UBS | Thomas Wadewitz | Neutral | Maintains | $15.00 |
| Nov 7, 2025 | Truist Securities | Lucas Servera | Buy | Maintains | $20.00 |
| Nov 7, 2025 | Barclays | Brandon Oglenski | Overweight | Maintains | $15.00 |
| Nov 7, 2025 | Susquehanna | Bascome Majors | Negative | Maintains | $10.00 |
| Oct 10, 2025 | Stifel | J. Bruce Chan | Hold | Maintains | $17.00 |
| Oct 9, 2025 | Goldman Sachs | Jordan Alliger | Neutral | Maintains | $15.00 |
| Oct 8, 2025 | JP Morgan | Brian Ossenbeck | Underweight | Maintains | $16.00 |
| Oct 3, 2025 | UBS | Thomas Wadewitz | Neutral | Maintains | $17.00 |
Rxo Inc. (RXO) Competitors
The following stocks are similar to RXO based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Rxo Inc. (RXO) Financial Data
Rxo Inc. has a market capitalization of $3.23B with a P/E ratio of 645.3x. The company generates $5.74B in trailing twelve-month revenue with a -1.7% profit margin.
Revenue growth is -11.9% quarter-over-quarter, while maintaining an operating margin of -0.6% and return on equity of -6.3%.
Valuation Metrics
Market Cap
$3.23B
Enterprise Value
$3.86B
P/E Ratio
645.3x
PEG Ratio
5.2x
Price/Sales
0.6x
Growth & Margins
Revenue Growth (YoY)
-11.9%
Gross Margin
+13.0%
Operating Margin
-0.6%
Net Margin
-1.7%
EPS Growth
-11.9%
Financial Health
Cash/Price Ratio
+0.5%
Current Ratio
1.3x
Debt/Equity
43.5x
ROE
-6.3%
ROA
-0.1%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
Rxo Inc. (RXO) Business Model
About Rxo Inc.
What They Do
Provides innovative shipping and logistics solutions.
Business Model
The company operates a comprehensive logistics network offering services like freight brokerage, last-mile delivery, and managed transportation. It generates revenue by leveraging technology to enhance operational efficiency, providing clients with cost-effective transportation solutions tailored to their needs.
Additional Information
Rxo Inc. emphasizes technological integration for route optimization and real-time tracking, which boosts client satisfaction. It plays a crucial role in the logistics and supply chain industry, addressing the demand for reliable distribution solutions and maintaining supply chain integrity.
Company Information
Sector
Industrials
Industry
Trucking
Employees
6,906
CEO
Mr. Drew M. Wilkerson
Country
United States
IPO Year
2022
Website
www.rxo.comRxo Inc. (RXO) Latest News & Analysis
Latest News
Quick Summary
RXO (NYSE: RXO) will release Q1 financial results on May 7, 2026, before market open. A conference call is scheduled for 8 a.m. EDT. Details available at www.rxo.com.
Why It Matters
RXO's upcoming financial results and conference call on May 7, 2026, will provide insights into the company's performance, impacting stock valuation and investor sentiment.
Source: Business Wire
Market Sentiment:
Neutral
RXO Announces Expansion of RXO Extra™ Carrier Rewards Program, Providing Truckers With More Benefits
27 days ago
Quick Summary
RXO (NYSE: RXO) expanded its RXO Extra™ marketplace, enhancing services for carriers to improve profitability and cash flow, including a premium load-booking experience.
Why It Matters
RXO's expansion of the RXO Extra marketplace enhances carrier profitability and cash flow, potentially increasing customer loyalty and market share, which may positively impact company revenue and stock performance.
Source: Business Wire
Market Sentiment:
Neutral
Quick Summary
RXO, Inc. presented at the JPMorgan Industrials Conference 2026, highlighting key insights and developments for investors. Further details can be found in the conference transcript.
Why It Matters
RXO's presentation at a major conference signals potential insights into its growth strategy and market position, influencing investor sentiment and stock performance.
Source: Seeking Alpha
Market Sentiment:
Neutral
RXO Leaders Recognized by Supply & Demand Chain Executive as “Pros to Know” for Fourth Consecutive Year
1 month ago
Quick Summary
RXO (NYSE: RXO) announced that Sandeep Pisipati, Matt Carlson, and Alyssa Slaughter were named 2026 Pros to Know by Supply & Demand Chain Executive, marking the fourth consecutive year for such recognition.
Why It Matters
RXO's recognition highlights its leadership in supply chain innovation, potentially boosting investor confidence and signaling strong operational performance and strategic positioning.
Source: Business Wire
Market Sentiment:
Neutral
Quick Summary
RXO (NYSE: RXO) reported an increase in truckload rates for Q4 and provided a forecast for Q1, indicating rising spot rates in the freight market.
Why It Matters
Rising truckload rates indicate increased demand for freight services, potentially boosting RXO's revenue. Positive market forecasts can enhance investor confidence and influence stock performance.
Source: Business Wire
Market Sentiment:
Neutral
Quick Summary
RXO (NYSE: RXO) announced participation in two investor conferences: Raymond James on March 2, 2026, and J.P. Morgan on March 17, 2026, featuring executives Jared Weisfeld and Kevin Sterling.
Why It Matters
Participation in key investor conferences signals RXO's commitment to transparency and engagement with investors, potentially influencing stock performance and investor confidence.
Source: Business Wire
Market Sentiment:
Neutral
Frequently Asked Questions About RXO Stock
What is Rxo Inc.'s (RXO) stock forecast for 2026?
Based on our analysis of 24 Wall Street analysts, Rxo Inc. (RXO) has a median price target of $15.00. The highest price target is $20.00 and the lowest is $12.00.
Is RXO stock a good investment in 2026?
According to current analyst ratings, RXO has 5 Buy ratings, 14 Hold ratings, and 2 Sell ratings. The stock is currently trading at $19.58. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for RXO stock?
Wall Street analysts predict RXO stock could reach $15.00 in the next 12 months. This represents a -23.4% decrease from the current price of $19.58. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Rxo Inc.'s business model?
The company operates a comprehensive logistics network offering services like freight brokerage, last-mile delivery, and managed transportation. It generates revenue by leveraging technology to enhance operational efficiency, providing clients with cost-effective transportation solutions tailored to their needs.
What is the highest forecasted price for RXO Rxo Inc.?
The highest price target for RXO is $20.00 from Lucas Servera at Truist Securities, which represents a 2.1% increase from the current price of $19.58.
What is the lowest forecasted price for RXO Rxo Inc.?
The lowest price target for RXO is $12.00 from Bascome Majors at Susquehanna, which represents a -38.7% decrease from the current price of $19.58.
What is the overall RXO consensus from analysts for Rxo Inc.?
The overall analyst consensus for RXO is neutral. Out of 24 Wall Street analysts, 5 rate it as Buy, 14 as Hold, and 2 as Sell, with a median price target of $15.00.
How accurate are RXO stock price projections?
Stock price projections, including those for Rxo Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: April 22, 2026 3:45 AM UTC